290 related articles for article (PubMed ID: 22988141)
21. TMEM16A mediates the hypersecretion of mucus induced by Interleukin-13.
Lin J; Jiang Y; Li L; Liu Y; Tang H; Jiang D
Exp Cell Res; 2015 Jun; 334(2):260-9. PubMed ID: 25770012
[TBL] [Abstract][Full Text] [Related]
22. TMEM16A in Cystic Fibrosis: Activating or Inhibiting?
Kunzelmann K; Ousingsawat J; Cabrita I; Doušová T; Bähr A; Janda M; Schreiber R; Benedetto R
Front Pharmacol; 2019; 10():3. PubMed ID: 30761000
[TBL] [Abstract][Full Text] [Related]
23. Time for TMEM?
Fuller CM
J Physiol; 2012 Dec; 590(23):5931-2. PubMed ID: 23204100
[No Abstract] [Full Text] [Related]
24. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
[TBL] [Abstract][Full Text] [Related]
25. Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction.
Huang F; Zhang H; Wu M; Yang H; Kudo M; Peters CJ; Woodruff PG; Solberg OD; Donne ML; Huang X; Sheppard D; Fahy JV; Wolters PJ; Hogan BL; Finkbeiner WE; Li M; Jan YN; Jan LY; Rock JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16354-9. PubMed ID: 22988107
[TBL] [Abstract][Full Text] [Related]
26. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
Danahay HL; Lilley S; Fox R; Charlton H; Sabater J; Button B; McCarthy C; Collingwood SP; Gosling M
Am J Respir Crit Care Med; 2020 Apr; 201(8):946-954. PubMed ID: 31898911
[No Abstract] [Full Text] [Related]
27. Anoctamin pharmacology.
Genovese M; Galietta LJV
Cell Calcium; 2024 Jul; 121():102905. PubMed ID: 38788257
[TBL] [Abstract][Full Text] [Related]
28. Potentiating TMEM16A does not stimulate airway mucus secretion or bronchial and pulmonary arterial smooth muscle contraction.
Danahay H; Fox R; Lilley S; Charlton H; Adley K; Christie L; Ansari E; Ehre C; Flen A; Tuvim MJ; Dickey BF; Williams C; Beaudoin S; Collingwood SP; Gosling M
FASEB Bioadv; 2020 Aug; 2(8):464-477. PubMed ID: 32821878
[TBL] [Abstract][Full Text] [Related]
29. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity.
Caputo A; Caci E; Ferrera L; Pedemonte N; Barsanti C; Sondo E; Pfeffer U; Ravazzolo R; Zegarra-Moran O; Galietta LJ
Science; 2008 Oct; 322(5901):590-4. PubMed ID: 18772398
[TBL] [Abstract][Full Text] [Related]
30. Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease.
Centeio R; Ousingsawat J; Cabrita I; Schreiber R; Talbi K; Benedetto R; Doušová T; Verbeken EK; De Boeck K; Cohen I; Kunzelmann K
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360618
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional characterization of TMEM16A, a Ca2+-activated Cl- channel activated by extracellular nucleotides, in biliary epithelium.
Dutta AK; Khimji AK; Kresge C; Bugde A; Dougherty M; Esser V; Ueno Y; Glaser SS; Alpini G; Rockey DC; Feranchak AP
J Biol Chem; 2011 Jan; 286(1):766-76. PubMed ID: 21041307
[TBL] [Abstract][Full Text] [Related]
32. Plasma membrane-localized TMEM16 proteins are indispensable for expression of CFTR.
Benedetto R; Ousingsawat J; Cabrita I; Pinto M; Lérias JR; Wanitchakool P; Schreiber R; Kunzelmann K
J Mol Med (Berl); 2019 May; 97(5):711-722. PubMed ID: 30915480
[TBL] [Abstract][Full Text] [Related]
33. TMEM16A-Mediated Mucin Secretion in IL-13-Induced Nasal Epithelial Cells From Chronic Rhinosinusitis Patients.
Zhang Y; Wang X; Wang H; Jiao J; Li Y; Fan E; Zhang L; Bachert C
Allergy Asthma Immunol Res; 2015 Jul; 7(4):367-75. PubMed ID: 25749771
[TBL] [Abstract][Full Text] [Related]
34. TMEM16A/F support exocytosis but do not inhibit Notch-mediated goblet cell metaplasia of BCi-NS1.1 human airway epithelium.
Centeio R; Cabrita I; Schreiber R; Kunzelmann K
Front Physiol; 2023; 14():1157704. PubMed ID: 37234411
[TBL] [Abstract][Full Text] [Related]
35. A fungus-derived purpactin A as an inhibitor of TMEM16A chloride channels and mucin secretion in airway epithelial cells.
Yimnual C; Satitsri S; Ningsih BNS; Rukachaisirikul V; Muanprasat C
Biomed Pharmacother; 2021 Jul; 139():111583. PubMed ID: 33901875
[TBL] [Abstract][Full Text] [Related]
36. Chronic rhinosinusitis with nasal polyps is associated with impaired TMEM16A-mediated epithelial chloride secretion.
Salomon JJ; Albrecht T; Graeber SY; Scheuermann H; Butz S; Schatterny J; Mairbäurl H; Baumann I; Mall MA
J Allergy Clin Immunol; 2021 Jun; 147(6):2191-2201.e2. PubMed ID: 33609628
[TBL] [Abstract][Full Text] [Related]
37. Modulation of TMEM16A channel activity by the von Willebrand factor type A (VWA) domain of the calcium-activated chloride channel regulator 1 (CLCA1).
Sala-Rabanal M; Yurtsever Z; Berry KN; Nichols CG; Brett TJ
J Biol Chem; 2017 Jun; 292(22):9164-9174. PubMed ID: 28420732
[TBL] [Abstract][Full Text] [Related]
38. Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic Fibrosis.
Pinto MC; Botelho HM; Silva IAL; Railean V; Neumann B; Pepperkok R; Schreiber R; Kunzelmann K; Amaral MD
J Mol Biol; 2022 Mar; 434(5):167436. PubMed ID: 34990652
[TBL] [Abstract][Full Text] [Related]
39. [Functional Expression of a Ca(2+)-activated Cl(-) Channel Modulator Involved in Ion Transport and Epithelial Cell Differentiation].
Yamazaki J
Yakugaku Zasshi; 2016; 136(3):485-90. PubMed ID: 26935091
[TBL] [Abstract][Full Text] [Related]
40. TMEM16A (ANO1) as a therapeutic target in cystic fibrosis.
Galietta LJV
Curr Opin Pharmacol; 2022 Jun; 64():102206. PubMed ID: 35364521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
